Is IVVD Worth Buying in 2026?

Invivyd, Inc. Common Stock

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-06-14

Here’s whether Invivyd, Inc. Common Stock (IVVD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-5.57% over 10 days); RSI 22 — oversold; 3-month momentum negative (-53.9%); rising volume on a downtrend (distribution, 1.35x avg). Currently 74.9% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

IVVD is trading below its 200-day MA ($1.70) — a key warning sign the longer-term trend is under pressure. An RSI of 22.0 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -9.1% compares to +22.9% for SPY (trailed the market by 31.9%). The current 74.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $9,093 today
vs. S&P 500 (SPY) — same period trailed market by 31.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.70)
Above 50-day MA ($1.33)
!RSI(14) neutral zone (30–70) — currently 22.0
Positive return (-9.1%)
!Within 10% of period high (−74.9%)
Period Range $0.77
$0.48 $3.07
RSI (14) 22.0
0 · OversoldOverbought · 100

Key Metrics

Price$0.77
Period Return-9.1%
Period High$3.07
Period Low$0.48
Drawdown−74.9%
MA-50$1.33
MA-200$1.70
RSI (14)22.0
Avg Volume (30d)3.8M
vs. SPYtrailed by 31.9%
Return Rank#786 of 1246

Trade IVVD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers